Evidence map›Paper›PMID 24480044›Full record

ArticleEpidemiology and infection2014

Use of laboratory-based surveillance data to estimate the number of people chronically infected with hepatitis B living in Scotland.

C Schnier, L Wallace, K Tempelton, C Aitken, R N Gunson, P Molyneaux, P McINTYRE, C Povey, D Goldberg, S Hutchinson

Open access · bronzeAbstract read
In one paragraph

Article in Epidemiology and infection, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Innovative strategies for the elimination of viral hepatitis at a national level: A country case series.Liver international : official journal of the International Association for the Study of the Liver · 2019
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

C SchnierSchool of Health and Life Sciences,Glasgow Caledonian University,Glasgow,UK.
L WallaceHealth Protection Scotland, Meridian Court, Glasgow,UK.
K TempeltonSpecialist Virology Centre, Royal Infirmary of Edinburgh, Edinburgh,UK.
C AitkenWest of Scotland Specialist Virology Centre,Gartnaval General Hospital, Glasgow,UK.
R N GunsonWest of Scotland Specialist Virology Centre,Gartnaval General Hospital, Glasgow,UK.
P MolyneauxDepartment of Medical Microbiology,Aberdeen Royal Infirmary,Aberdeen,UK.
P McINTYREDepartment of Medical Microbiology,Ninewells Hospital & Medical School,Dundee,UK.
C PoveyInformation Service Division Scotland, Edinburgh,UK.
D GoldbergHealth Protection Scotland, Meridian Court, Glasgow,UK.
S HutchinsonSchool of Health and Life Sciences,Glasgow Caledonian University,Glasgow,UK.
Health Protection Scotland · GBGartnavel General Hospital · GBAberdeen Royal Infirmary · GBEdinburgh Royal Infirmary · GBNational Health Service Scotland · GBNinewells Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is paramount to understand the epidemiology of chronic hepatitis B to inform national policies on vaccination and screening/testing as well as cost-effectiveness studies. However, information on the national (Scottish) prevalence of chronic hepatitis B by ethnic group is lacking. To estimate the number of people with chronic hepatitis B in Scotland in 2009 by ethnicity, gender and age, the test data from virology laboratories in the four largest cities in Scotland were combined with estimates of the ethnic distribution of the Scottish population. Ethnicity in both the test data and the Scottish population was derived using a name-based ethnicity classification software (OnoMAP; Publicprofiler Ltd, UK). For 2009, we estimated 8720 [95% confidence interval (CI) 7490-10 230] people aged ⩾15 years were living with chronic hepatitis B infection in Scotland. This corresponds to 0·2% (95% CI 0·17-0·24) of the Scottish population aged ⩾15 years. Although East and South Asians make up a small proportion of the Scottish population, they make up 44% of the infected population. In addition, 75% of those infected were aged 15-44 years with almost 60% male. This study quantifies for the first time on a national level the burden of chronic hepatitis B infection by ethnicity, gender and age. It confirms the importance of promoting and targeting ethnic minority groups for hepatitis B testing.

Indexed as

LaboratoriesVirologyAdolescentAdultAge DistributionAsia, EasternAsian PeopleAsia, WesternEpidemiological MonitoringEthnicityFemaleHealth Services Needs and DemandHepatitis B, ChronicHumansMaleMiddle Aged

Identifiers

PMID24480044
PMCPMC9151307
OpenAlexW2317164280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.